The contribution of serum adiponectin and resistin as biomarkers of insulin resistance and development of the metabolic syndrome among women with PCOS has been a matter of debate during the last years (15, 16, 17, 18). This evidence concerns the gene ADIPOQ and metabolic syndrome.